Calidi Biotherapeutics Stock Forecast

Hold candidate since Jun 18, 2026

The Calidi Biotherapeutics, Inc. stock price gained 11.12% on the last trading day (Thursday, 18th Jun 2026), rising from $0.152 to $0.169. During the last trading day the stock fluctuated 10.25% from a day low at $0.154 to a day high of $0.170. The price has fallen in 6 of the last 10 days and is down by -2.93% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $1.57 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.86% during the next 3 months and, with a 90% probability hold a price between $0.0871 and $0.107 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CLDI Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 17, 2026, and so far it has risen 11.12%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Calidi Biotherapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.185. On a fall, the stock will find some support from the short-term average at $0.162. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Calidi Biotherapeutics, Inc. stock

Calidi Biotherapeutics, Inc. finds support from accumulated volume at $0.166 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0158 between high and low, or 10.25%. For the last week, the stock has had daily average volatility of 15.78%.

Our recommended stop-loss: $0.162 (-4.16%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (CLDI) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Calidi Biotherapeutics, Inc. to open at $0.164, and during the day (based on 14 day Average True Range), to move between $0.160 and $0.178, which gives a possible trading interval of +/-$0.0185 (+/-11.56%) up or down from last closing price. If Calidi Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 11.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.169 (0.06%) than the support at $0.166 (1.95%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Calidi Biotherapeutics, Inc. stock A Buy?

Calidi Biotherapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Hold candidate.

Current score: -0.910 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $0.164 ( 2.68%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk